Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management. (PBS-MHE-2019)

Development and Efficiency of an mHealth Intervention on the Health Literacy Improvement and Self-management of the Multi-pathological Patient With Heart Failure: a Randomized Controlled Trial.

Multipathological patients with complex health needs are responsible for the majority number of avoidable hospital admissions.

The expansion of mHealth interventions in the field of communication with the patient, the reduction of health inequalities, the improvement in access to health resources, the adherence to treatments and self-care of chronic diseases lead to an optimistic horizon . However, there are few applications that demonstrate its effectiveness in these patients, which is diminished when they are not based on evidence, nor are designed by and for users with different levels of health literacy.

Study Overview

Status

Recruiting

Detailed Description

Objective: to evaluate the efficacy of an mHealth intervention, with respect to routine clinical practice, to improve health literacy and self-management of the multiple pathological patient with heart failure and complex health needs.

Hypothesis: the proposed mHealth intervention is more effective than usual clinical practice, favoring health literacy and self-management of multiple pathological patients with heart failure and complex health needs, so its use would be relevant as part of the assistance process.

Methodology: randomized, controlled, multicenter clinical trial for the evaluation of the efficacy of an mHealth intervention with two groups: a control group (routine clinical practice) and an experimental group (routine clinical practice together with ad hoc designed mHealth intervention).

In this project, the design and content validation of the mHealth tool will be carried out, evaluating its relevance and suitability.

Study Type

Interventional

Enrollment (Anticipated)

236

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Cadiz, Spain, 11009
        • Recruiting
        • F. para la Gestión de la Inv. Biomédica de Cádiz Ríos
        • Contact:
    • Cádiz
      • Algeciras, Cádiz, Spain, 11207
        • Active, not recruiting
        • Health Management area of Gibraltar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients of both sexes and over 18 years of age;
  • Attended by the health professionals of the Basic Health Areas that are participating in the study;
  • Patients that give their consent to participate in the study by signing an informed consent;
  • Patients that have a mobile device (Smartphone or Tablet) compatible with the Android or iOS operating system;
  • Patients considered as multi-pathological based on the following criteria from those described in the Integrated Healthcare Process (Ollero et al., 2018):
  • Be classified in clinical category A of chronic pathologies due to heart failure that, in a situation of clinical stability, has been in NYHA grade II, being able to be simultaneously classified, or not, in other clinical categories due to suffering from another disease Chronicles.
  • Patients with at least one of the following complexity criteria: Extreme polypharmacy (10 or more active ingredients for chronic prescription); Socio-family risk (score on the Gijon scale greater than 10 points); Stage II or higher pressure ulcers; Malnutrition (BMI <18.5); Feeding with chronic and prescription tube (3 or more months); Two or more hospital admissions in the previous 12 months.

Exclusion Criteria:

  • Patients with sensory deficits and/or mobility problems in the upper limbs that prevent them from using the application correctly, despite using the accessibility features of mobile devices;
  • Patients with persistent cognitive impairment (Pfeiffer test with 5 or more errors or Lobo's mini-cognitive exam <23 points) and / or severe mental disorder;
  • Patients with serious limitations for AVBD (Barthel index <20 points).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: usual clinical practice
A group of pluripatological patients with heart failure and complex needs of health will be tratad per standard of care on site
Experimental: mHealth intervention plus usual clinical practice
A group of pluripatological patients with heart failure and complex needs of health will be tratad per standard of care plus mHealth intervention on site
MHealth (mobile health) intervention is an act whose purpose is to improve, maintain, promote or modify health, functioning or health conditions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health literacy
Time Frame: 1 year
Literacy on health defined by points (range 0-50)
1 year
General selfmanagement
Time Frame: 1 year
Selfmanagement on health (scale 1-5)
1 year
selfmanagement on heart failure
Time Frame: 1 year
European Heart Failure SelfCare Behavior Scale (range 12-60)
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-independence
Time Frame: 1 year
Personal grade of self-independence- Barthel Index
1 year
self-independence 2
Time Frame: 1 year
Personal grade of self-independence- Lawton and Brody Index
1 year
Adherence to treatments
Time Frame: 1 year
Adherence to treatments measured by Morisky-Green Questionnaire
1 year
Prognosis
Time Frame: 1 year
Life prognosis using PROFUND Index
1 year
Patient satisfaction
Time Frame: 1 year
General patient satisfaction using a simple questionnarie
1 year
Patient satisfaction 2
Time Frame: 1 year
Patients satisfaction related to mHealth device
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pilar Bas Sarmiento, MD, Instituto de investigación e innovación biomédica de Cádiz
  • Principal Investigator: Martina Fernández Gutiérrez, Instituto de investigación e innovación biomédica de Cádiz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Anticipated)

January 1, 2023

Study Completion (Anticipated)

January 1, 2024

Study Registration Dates

First Submitted

December 10, 2020

First Submitted That Met QC Criteria

January 25, 2021

First Posted (Actual)

January 26, 2021

Study Record Updates

Last Update Posted (Actual)

August 8, 2022

Last Update Submitted That Met QC Criteria

August 5, 2022

Last Verified

December 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PBS-MHE-2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Mobile phone compatible with iOS or Android

Subscribe